Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ERLIN2 contributors: npt/shn/mct - updated : 06-01-2016
HGNC name ER lipid raft associated 2
HGNC id 1356
DNA
TYPE functioning gene
STRUCTURE 21.22 kb     12 Exon(s)
MAPPING cloned Y linked   status provisional
Map pter - D8S1747 - D8S571 - ERLIN2 - D8S1722 - D8S536 - qter
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
12 splicing 4836 37 339 - -
7 splicing 1538 - 152 - -
7 splicing 1765 - 152 - -
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveintestinesmall intestine   
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Connectivebone   
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period pregnancy
Text placenta
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • extreme N-terminus of ERLIN2 were found to be sufficient for heterologous targeting of GFP to the ER in the absence of classical ER retrieval motifs
  • a SPFH domain
  • HOMOLOGY
    interspecies ortholog to Erlin2, Mus musculus
    ortholog to Erlin2, Rattus norvegicus
    ortholog to erlin2, Danio rerio
    ortholog to ERLIN2, Pan troglodytes
    Homologene
    FAMILY
  • prohibitin domain containing family of proteins
  • CATEGORY unknown/unspecified
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,endoplasmic reticulum
    text
  • reside in detergent resistant membranes (DRMs) in the ER
  • basic FUNCTION
  • a mediator of the endoplasmic reticulum degradation (ERAD) pathway
  • ERLIN1/ERLIN2 complex is a factor that selectively mediates the ERAD of activated IP(3) receptors
  • novel mediator of ER-associated degradation
  • is a novel oncogenic factor associated with the ER stress response pathway
  • may confer a selective growth advantage for breast cancer cells by facilitating a cytoprotective response to various cellular stresses associated with oncogenesis
  • is a regulator of cytosolic lipid content in cancer cells has important implications for understanding the molecular basis of tumorigenesis and the treatment of cancer
  • gamma-secretase associated protein (GSAP), residing in detergent resistant membranes (DRMs) in the ER
  • ERLIN1, ERLIN2 promote stability of the SREBF-SCAP-INSIG complex and may contribute to the highly cooperative control of this system
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • ERLIN1/2 complex is composed of an assemblage of lower-order hetero-oligomers, probably heterotrimers, linked together by assembly domain hydrophobic AAs
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • form a heterodimer with SPFH1 (
  • ER membrane proteins, ERLIN2 and TMUB1, are associated proteins of mammalian AMFR, a membrane-bound ubiquitin ligase that mediates sterol-accelerated ERAD of the cholesterol biosynthetic enzyme HMGCR
  • associated with active gamma-secretase in brain tissue (GSAP)
  • interacts with gamma-secretase in brain, and reduces APP production while the effect on notch processing is limited
  • multimeric ER proteins ERLIN1 and ERLIN2 are additional SREBF1, SREBF2 regulators
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) IDMDC , SPG18 , PLSJ2
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    of ZNF703, ERLIN2, PROSC, GPR124, and BRF2 in urothelial carcinoma
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    neurologyneurodegenerativealzheimer
    interfering with the ERLIN2/gamma-secretase interaction might reduce APP production without affecting Notch processing, and thus be a pharmacological strategy for treatment of AD
    ANIMAL & CELL MODELS